SCHEMBL16587444

SCHEMBL16587444

CS(=O)(=O)c1cccc(-c2nc(-c3c(Br)c(C(=O)CO)nn3-c3ccccc3Cl)no2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 8/20 0.44
NR1H3 Q13133 8/20 0.44
RXRA P19793 7/20 0.44
S1PR1 P21453 1/20 0.43
CPT2 P23786 1/20 0.38
CPT1A P50416 1/20 0.38
CA9 Q16790 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CNR1 P21554 2/20 0.36
RAB9A P51151 2/20 0.35
KMT2A Q03164 1/20 0.35
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
MCTS1 Q9ULC4 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16587445 0.91 RXRA (0.46) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16455252 0.91 NR1H2 (0.46) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16455610 0.88 RXRA (0.53) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16587286 0.88 NPC1 (0.43) CNR1RAB9ATP53NPC1SMN1; SMN2
SCHEMBL15242880 0.88 NR1H2 (0.46) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16455248 0.84 NR1H2 (0.47) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16587446 0.84 RXRA (0.46) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16455605 0.83 RXRA (0.53) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16455621 0.82 RXRA (0.54) NR1H2NR1H3RXRAS1PR1CPT2
SCHEMBL16455620 0.82 NR1H2 (0.45) NR1H2NR1H3RXRAS1PR1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987318-B2 Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions ALEXAR THERAPEUTICS, INC. (US) 2015-03-24 US disclosed